OMX Stockholm PI
958,92
PKT
-0,66
PKT
-0,07
%
Werbung
Analysen zu OMX Stockholm PI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
15.12.14 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
11.12.14 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | UBS AG | |
11.12.14 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | UBS AG | |
11.12.14 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
10.12.14 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
09.12.14 | AstraZeneca buy | Merrill Lynch & Co., Inc. | |
09.12.14 | ABB (Asea Brown Boveri) Equal weight | Barclays Capital | |
05.12.14 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
04.12.14 | Nokia overweight | JP Morgan Chase & Co. | |
03.12.14 | AstraZeneca Underweight | Morgan Stanley | |
01.12.14 | Volvo (B) Hold | Deutsche Bank AG | |
01.12.14 | Volvo (B) Outperform | Credit Suisse Group | |
26.11.14 | Volvo (B) Underweight | Morgan Stanley | |
26.11.14 | AstraZeneca buy | UBS AG | |
25.11.14 | AstraZeneca Outperform | BNP PARIBAS | |
24.11.14 | Nokia buy | Citigroup Corp. | |
21.11.14 | Nokia Halten | Independent Research GmbH | |
21.11.14 | Volvo (B) Sell | S&P Capital IQ | |
19.11.14 | AstraZeneca Underweight | JP Morgan Chase & Co. | |
19.11.14 | AstraZeneca buy | Citigroup Corp. | |
18.11.14 | AstraZeneca buy | UBS AG | |
17.11.14 | Nokia Neutral | UBS AG | |
17.11.14 | Nokia overweight | JP Morgan Chase & Co. | |
17.11.14 | Ericsson (Telefon L.M.Ericsson) (B) overweight | JP Morgan Chase & Co. | |
17.11.14 | AstraZeneca neutral | Barclays Capital | |
15.11.14 | Nokia Sell | S&P Capital IQ | |
14.11.14 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | Citigroup Corp. | |
14.11.14 | Ericsson (Telefon L.M.Ericsson) (B) Underweight | Barclays Capital | |
14.11.14 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | UBS AG | |
14.11.14 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
13.11.14 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
13.11.14 | AstraZeneca Underweight | JP Morgan Chase & Co. | |
11.11.14 | Volvo (B) Sell | Goldman Sachs Group Inc. | |
10.11.14 | AstraZeneca buy | Jefferies & Company Inc. | |
10.11.14 | Nokia overweight | JP Morgan Chase & Co. | |
07.11.14 | AstraZeneca neutral | Independent Research GmbH | |
07.11.14 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
06.11.14 | AstraZeneca Hold | S&P Capital IQ | |
04.11.14 | AstraZeneca buy | UBS AG | |
04.11.14 | Nokia Underperform | Bernstein Research |